According to the latest report published by Data Bridge Market Research, the Antisense Oligonucleotide for Genetic and Rare Disorders Market  CAGR Value The global antisense oligonucleotide for genetic and rare disorders market size was valued at USD 529.26 billion in 2024 and is expected to reach USD 1,563.55 billion by 2032, at a CAGR of...